LANZAFAME, Helena
LANZAFAME, Helena
Dipartimento di Scienze biomediche, odontoiatriche e delle immagini morfologiche e funzionali
A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy
2019-01-01 Laudicella, R; Minutoli, F; Comis, Ad; Vento, A; Lanzafame, H; Catalfamo, B; Panasiti, F; Mantarro, C; Pignata, Sa; Pagano, B; Baldari, S
Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomics Classification for Prediction of Disease Outcome
2022-01-01 Alongi, Pierpaolo; Stefano, Alessandro; Comelli, Albert; Spataro, Alessandro; Formica, Giuseppe; Laudicella, Riccardo; Lanzafame, Helena; Panasiti, Francesco; Longo, Costanza; Midiri, Federico; Benfante, Viviana; La Grutta, Ludovico; Andrea Burger, Irene; Vincenzo Bartolotta, Tommaso; Baldari, Sergio; Lagalla, Roberto; Midiri, Massimo; Russo, Giorgio
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy
2019-01-01 Giuffrè, G.; Campennì, A.; Ieni, A.; Germanà, E.; Simone, A.; Scarfì, R.; Piserà, A.; Pitasi, C.; Ruggeri, R. M.; Lanzafame, H.; Dionigi, G.; Tuccari, G.
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer
2021-01-01 Campenni, Alfredo; Ruggeri, Rosaria M.; Giuffre', Giuseppe; Siracusa, Massimiliano; Alibrandi, Angela; Cardile, Davide; La Torre, Flavia; Lanzafame, Helena; Giacoppo, Giulia; Ieni, Antonio; Trimarchi, Francesco; Tuccari, Giovanni; Baldari, Sergio
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients
2021-01-01 Campenni', Alfredo; Ruggeri, Rosaria M.; Siracusa, Massimiliano; Comis, Alessio Danilo; Romano, Davide; Vento, Antonio; Lanzafame, Helena; Capoccetti, Francesca; Alibrandi, Angela; Baldari, Sergio; Giovanella, Luca
Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience
2019-01-01 Laudicella, R; Minutoli, F; Comis, Ad; Lanzafame, H; Catalfamo, B; Panasiti, F; Mantarro, C; Pagano, B; Baldari, S
Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature
2023-01-01 Guglielmo, Priscilla; Alongi, Pierpaolo; Baratto, Lucia; Abenavoli, Elisabetta; Buschiazzo, Ambra; Celesti, Greta; Conte, Miriam; Filice, Rossella; Gorica, Joana; Jonghi-Lavarini, Lorenzo; Lanzafame, Helena; Laudicella, Riccardo; Librando, Maria; Linguanti, Flavia; Mattana, Francesco; Miceli, Alberto; Olivari, Laura; Piscopo, Leandra; Romagnolo, Cinzia; Santo, Giulia; Vento, Antonio; Volpe, Fabio; Evangelista, Laura
Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience
2019-01-01 Pignata, SALVATORE ANTONIO; Campenni', Alfredo; Laudicella, Riccardo; Quattrocchi, FLAVIA MARIA ENZA; Comis, Alessio Danilo; Vento, Antonio; Lanzafame, Helena; Mantarro, Cristina; Amato, Ernesto; Pagano, Benedetta; Cardile, Davide; Minutoli, Fabio; Baldari, Sergio
Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients
2019-01-01 Pignata, S; Minutoli, F; Catalfamo, B; Lanzafame, H; Panasiti, F; Mantarro, C; Filice, R; Laudicella, R; Cardile, D; Russo, S; Martino, M; Baldari, S
PRRT Retreatments: Renal Function Evaluation
2019-01-01 Laudicella, Riccardo; Minutoli, Fabio; Vento, Antonio; Comis, Alessio Danilo; Filice, Rossella; Lanzafame, Helena; Catalfamo, Barbara; Mantarro, Cristina; Pagano, Benedetta; Baldari, Sergio
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature
2022-01-01 Alongi, P.; Laudicella, R.; Lanzafame, H.; Farolfi, A.; Mapelli, P.; Picchio, M.; Burger, I. A.; Iagaru, A.; Minutoli, F.; Evangelista, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Single Centre Experience with 223-Radium-Dichloride ((RaCl2)-Ra-223) Therapy | 1-gen-2019 | Laudicella, R; Minutoli, F; Comis, Ad; Vento, A; Lanzafame, H; Catalfamo, B; Panasiti, F; Mantarro, C; Pignata, Sa; Pagano, B; Baldari, S | |
| Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomics Classification for Prediction of Disease Outcome | 1-gen-2022 | Alongi, Pierpaolo; Stefano, Alessandro; Comelli, Albert; Spataro, Alessandro; Formica, Giuseppe; Laudicella, Riccardo; Lanzafame, Helena; Panasiti, Francesco; Longo, Costanza; Midiri, Federico; Benfante, Viviana; La Grutta, Ludovico; Andrea Burger, Irene; Vincenzo Bartolotta, Tommaso; Baldari, Sergio; Lagalla, Roberto; Midiri, Massimo; Russo, Giorgio | |
| BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy | 1-gen-2019 | Giuffrè, G.; Campennì, A.; Ieni, A.; Germanà, E.; Simone, A.; Scarfì, R.; Piserà, A.; Pitasi, C.; Ruggeri, R. M.; Lanzafame, H.; Dionigi, G.; Tuccari, G. | |
| BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer | 1-gen-2021 | Campenni, Alfredo; Ruggeri, Rosaria M.; Giuffre', Giuseppe; Siracusa, Massimiliano; Alibrandi, Angela; Cardile, Davide; La Torre, Flavia; Lanzafame, Helena; Giacoppo, Giulia; Ieni, Antonio; Trimarchi, Francesco; Tuccari, Giovanni; Baldari, Sergio | |
| Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients | 1-gen-2021 | Campenni', Alfredo; Ruggeri, Rosaria M.; Siracusa, Massimiliano; Comis, Alessio Danilo; Romano, Davide; Vento, Antonio; Lanzafame, Helena; Capoccetti, Francesca; Alibrandi, Angela; Baldari, Sergio; Giovanella, Luca | |
| Effectiveness, safety and haematological toxicity of 223Ra-Cl2: a single centre experience | 1-gen-2019 | Laudicella, R; Minutoli, F; Comis, Ad; Lanzafame, H; Catalfamo, B; Panasiti, F; Mantarro, C; Pagano, B; Baldari, S | |
| Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature | 1-gen-2023 | Guglielmo, Priscilla; Alongi, Pierpaolo; Baratto, Lucia; Abenavoli, Elisabetta; Buschiazzo, Ambra; Celesti, Greta; Conte, Miriam; Filice, Rossella; Gorica, Joana; Jonghi-Lavarini, Lorenzo; Lanzafame, Helena; Laudicella, Riccardo; Librando, Maria; Linguanti, Flavia; Mattana, Francesco; Miceli, Alberto; Olivari, Laura; Piscopo, Leandra; Romagnolo, Cinzia; Santo, Giulia; Vento, Antonio; Volpe, Fabio; Evangelista, Laura | |
| Peptide Receptor Radionuclide Therapy and Somatostatin 'cold' Analogues Therapy in the Treatment of GEP-NET Patients: Our Center’ Experience | 1-gen-2019 | Pignata, SALVATORE ANTONIO; Campenni', Alfredo; Laudicella, Riccardo; Quattrocchi, FLAVIA MARIA ENZA; Comis, Alessio Danilo; Vento, Antonio; Lanzafame, Helena; Mantarro, Cristina; Amato, Ernesto; Pagano, Benedetta; Cardile, Davide; Minutoli, Fabio; Baldari, Sergio | |
| Prognostic Validity of Dual Tracer PET/CT In The PRRT Enrollment of GEP-NET Patients | 1-gen-2019 | Pignata, S; Minutoli, F; Catalfamo, B; Lanzafame, H; Panasiti, F; Mantarro, C; Filice, R; Laudicella, R; Cardile, D; Russo, S; Martino, M; Baldari, S | |
| PRRT Retreatments: Renal Function Evaluation | 1-gen-2019 | Laudicella, Riccardo; Minutoli, Fabio; Vento, Antonio; Comis, Alessio Danilo; Filice, Rossella; Lanzafame, Helena; Catalfamo, Barbara; Mantarro, Cristina; Pagano, Benedetta; Baldari, Sergio | |
| PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature | 1-gen-2022 | Alongi, P.; Laudicella, R.; Lanzafame, H.; Farolfi, A.; Mapelli, P.; Picchio, M.; Burger, I. A.; Iagaru, A.; Minutoli, F.; Evangelista, L. |